193 related articles for article (PubMed ID: 24909162)
21. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Permuth-Wey J; Lawrenson K; Shen HC; Velkova A; Tyrer JP; Chen Z; Lin HY; Chen YA; Tsai YY; Qu X; Ramus SJ; Karevan R; Lee J; Lee N; Larson MC; Aben KK; Anton-Culver H; Antonenkova N; Antoniou AC; Armasu SM; ; ; Bacot F; Baglietto L; Bandera EV; Barnholtz-Sloan J; Beckmann MW; Birrer MJ; Bloom G; Bogdanova N; Brinton LA; Brooks-Wilson A; Brown R; Butzow R; Cai Q; Campbell I; Chang-Claude J; Chanock S; Chenevix-Trench G; Cheng JQ; Cicek MS; Coetzee GA; ; Cook LS; Couch FJ; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Despierre E; Doherty JA; Dörk T; du Bois A; Dürst M; Easton DF; Eccles D; Edwards R; Ekici AB; Fasching PA; Fenstermacher DA; Flanagan JM; Garcia-Closas M; Gentry-Maharaj A; Giles GG; Glasspool RM; Gonzalez-Bosquet J; Goodman MT; Gore M; Górski B; Gronwald J; Hall P; Halle MK; Harter P; Heitz F; Hillemanns P; Hoatlin M; Høgdall CK; Høgdall E; Hosono S; Jakubowska A; Jensen A; Jim H; Kalli KR; Karlan BY; Kaye SB; Kelemen LE; Kiemeney LA; Kikkawa F; Konecny GE; Krakstad C; Kjaer SK; Kupryjanczyk J; Lambrechts D; Lambrechts S; Lancaster JM; Le ND; Leminen A; Levine DA; Liang D; Lim BK; Lin J; Lissowska J; Lu KH; Lubiński J; Lurie G; Massuger LF; Matsuo K; McGuire V; McLaughlin JR; Menon U; Modugno F; Moysich KB; Nakanishi T; Narod SA; Nedergaard L; Ness RB; Nevanlinna H; Nickels S; Noushmehr H; Odunsi K; Olson SH; Orlow I; Paul J; Pearce CL; Pejovic T; Pelttari LM; Pike MC; Poole EM; Raska P; Renner SP; Risch HA; Rodriguez-Rodriguez L; Rossing MA; Rudolph A; Runnebaum IB; Rzepecka IK; Salvesen HB; Schwaab I; Severi G; Shridhar V; Shu XO; Shvetsov YB; Sieh W; Song H; Southey MC; Spiewankiewicz B; Stram D; Sutphen R; Teo SH; Terry KL; Tessier DC; Thompson PJ; Tworoger SS; van Altena AM; Vergote I; Vierkant RA; Vincent D; Vitonis AF; Wang-Gohrke S; Palmieri Weber R; Wentzensen N; Whittemore AS; Wik E; Wilkens LR; Winterhoff B; Woo YL; Wu AH; Xiang YB; Yang HP; Zheng W; Ziogas A; Zulkifli F; Phelan CM; Iversen E; Schildkraut JM; Berchuck A; Fridley BL; Goode EL; Pharoah PD; Monteiro AN; Sellers TA; Gayther SA
Nat Commun; 2013; 4():1627. PubMed ID: 23535648
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel variant, 1484delG in the 3'UTR of H3F3B, a member of the histone 3B replacement family, in ovarian tumors.
Presneau N; Shen Z; Provencher D; Mes-Masson AM; Tonin PN
Int J Oncol; 2005 Jun; 26(6):1621-7. PubMed ID: 15870878
[TBL] [Abstract][Full Text] [Related]
23. HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.
Schwich E; Rebmann V; Michita RT; Rohn H; Voncken JW; Horn PA; Kimmig R; Kasimir-Bauer S; Buderath P
Sci Rep; 2019 Apr; 9(1):5407. PubMed ID: 30932005
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatics Analysis Revealed Novel 3'UTR Variants Associated with Intellectual Disability.
Yang J; Liu A; He I; Bai Y
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32858868
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
Ying X; Wei K; Lin Z; Cui Y; Ding J; Chen Y; Xu B
Cell Physiol Biochem; 2016; 39(2):501-10. PubMed ID: 27383536
[TBL] [Abstract][Full Text] [Related]
26. Gain-of-function microRNA screens identify miR-193a regulating proliferation and apoptosis in epithelial ovarian cancer cells.
Nakano H; Yamada Y; Miyazawa T; Yoshida T
Int J Oncol; 2013 Jun; 42(6):1875-82. PubMed ID: 23588298
[TBL] [Abstract][Full Text] [Related]
27. ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma.
Salzman J; Marinelli RJ; Wang PL; Green AE; Nielsen JS; Nelson BH; Drescher CW; Brown PO
PLoS Biol; 2011 Sep; 9(9):e1001156. PubMed ID: 21949640
[TBL] [Abstract][Full Text] [Related]
28. Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues.
Chen JL; Chen F; Zhang TT; Liu NF
Int J Mol Med; 2016 Jun; 37(6):1601-10. PubMed ID: 27081781
[TBL] [Abstract][Full Text] [Related]
29. Identification of sequence nucleotide polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for epithelial ovarian cancer.
Liu S; Shi S; Li Y; Kong D
Mitochondrial DNA A DNA Mapp Seq Anal; 2016; 27(1):9-11. PubMed ID: 24438298
[TBL] [Abstract][Full Text] [Related]
30. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
[TBL] [Abstract][Full Text] [Related]
31. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.
Zhou B; Xu H; Xia M; Sun C; Li N; Guo E; Guo L; Shan W; Lu H; Wu Y; Li Y; Yang D; Weng D; Meng L; Hu J; Ma D; Chen G; Li K
Front Med; 2017 Jun; 11(2):214-222. PubMed ID: 28470508
[TBL] [Abstract][Full Text] [Related]
32. The rs17084733 variant in the
Ravegnini G; Serrano C; Simeon V; Sammarini G; Nannini M; Roversi E; Urbini M; Ferrè F; Ricci R; Tarantino G; Pantaleo MA; Hrelia P; Angelini S
Epigenetics; 2019 Jun; 14(6):545-557. PubMed ID: 30983504
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
Teng Y; Zhang Y; Qu K; Yang X; Fu J; Chen W; Li X
Oncotarget; 2015 Dec; 6(38):40799-814. PubMed ID: 26512921
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
Liu J; Jin S; Wang R
Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
[TBL] [Abstract][Full Text] [Related]
35. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Richards EJ; Permuth-Wey J; Li Y; Chen YA; Coppola D; Reid BM; Lin HY; Teer JK; Berchuck A; Birrer MJ; Lawrenson K; Monteiro AN; Schildkraut JM; Goode EL; Gayther SA; Sellers TA; Cheng JQ
Oncotarget; 2015 Oct; 6(33):34745-57. PubMed ID: 26430965
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
Permuth-Wey J; Chen Z; Tsai YY; Lin HY; Chen YA; Barnholtz-Sloan J; Birrer MJ; Chanock SJ; Cramer DW; Cunningham JM; Fenstermacher D; Fridley BL; Garcia-Closas M; Gayther SA; Gentry-Maharaj A; Gonzalez-Bosquet J; Iversen E; Jim H; McLaughlin J; Menon U; Narod SA; Phelan CM; Ramus SJ; Risch H; Song H; Sutphen R; Terry KL; Tyrer J; Vierkant RA; Wentzensen N; Lancaster JM; Cheng JQ; Berchuck A; Pharoah PD; Schildkraut JM; Goode EL; Sellers TA;
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1793-7. PubMed ID: 21636674
[TBL] [Abstract][Full Text] [Related]
37. Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.
Koestler DC; Chalise P; Cicek MS; Cunningham JM; Armasu S; Larson MC; Chien J; Block M; Kalli KR; Sellers TA; Fridley BL; Goode EL
BMC Med Genomics; 2014 Jan; 7():8. PubMed ID: 24479488
[TBL] [Abstract][Full Text] [Related]
38. Polymorphisms in the MUC16 gene: potential implication in epithelial ovarian cancer.
Bouanene H; Hadj Kacem H; Ben Fatma L; Ben Limem H; Ben Ahmed S; Yakoub S; Miled A
Pathol Oncol Res; 2011 Jun; 17(2):295-9. PubMed ID: 21046495
[TBL] [Abstract][Full Text] [Related]
39. BRCA1, microRNAs and cancer predisposition: challenging the dogma.
Almeida MI; Reis RM; Calin GA
Cell Cycle; 2011 Feb; 10(3):377. PubMed ID: 21270524
[No Abstract] [Full Text] [Related]
40. Rs884225 polymorphism is associated with primary hypertension by compromising interaction between epithelial growth factor receptor (EGFR) and miR-214.
Luo F; Wu Y; Ding Q; Yuan Y; Jia W
J Cell Mol Med; 2021 Apr; 25(8):3714-3723. PubMed ID: 33635564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
